Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 17Sarcoma 6Sarcoma, Ewing 5Osteosarcoma 5Neoplasm Metastasis 4Rhabdomyosarcoma 3Colorectal Neoplasms 3Mesothelioma, Malignant 2Hemangiosarcoma 2Chondrosarcoma 2Bone Neoplasms 2Wilms Tumor 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thymoma 1Tertiary Lymphoid Structures 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Piebaldism 1Patient Compliance 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1

Interventions

regorafenib 1pazopanib 1Trabectedin 1Sirolimus 1Radiotherapy 1Radiation 1Pharmacogenomic Testing 1Ifosfamide 1HhAntag691 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma, Mesenchymal × regorafenib × Sarcoma × Clear all
NCT02048371 2023-11-07

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
131 enrolled 22 charts
Sarcoma

Liposarcoma, Rhabdomyosarcoma, Osteosarcoma, Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡